Outlook Therapeutics jobs and careers
Woodbridge Township, NJ, United States
About Outlook Therapeutics
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, including wet AMD, DME and BRVO.
Founded in 2011 by Pankaj Mohan.
- Founded
- 2011
- Employees
- 11 to 50
- Total funding
- $340.3M
- Headquarters
- Woodbridge Township
Leadership
The top of Outlook Therapeutics's org chart, with how many people report into each leader.
Terry Dagnon
COO
10 reports
Jennifer Kissner
Executive Vice President, Medical, Clinical, & Regulatory Affairs
5 reports
Lawrence A. Kenyon
CFO and Director
4 reports
Surendra Sharma
Senior Vice President, Medical Affairs
1 report
Dan Courtney
Consultant
Alison Oliver
Strategic Project Lead, Europe
Christopher Yonan
Senior Vice President - Technical Operations
3 reports
Lauren Nelson
Executive Director, Patient Access, Advocacy & Marketing
1 report
Jedd Comiskey
SVP Head of Europe
1 report
Danielle Greene
Senior Director Of Talent Acquisition And HR Strategy
Entisar Dahan, MPM, PHR
Director Human Resources
George Bitar
Vice President- Global Head of Quality
1 report
Kathleen Billman
Executive Director, Clinical Affairs
Kolleen Fitzgerald
Senior Director of Pharmacovigilance
Board
Gerd Auffarth
Director
Andong Huang
Director
Randy Thurman
Chairman
Faisal G. Sukhtian
Director
Kurt J. Hilzinger
Director
Julian Gangolli
Director
Jobs at Outlook Therapeutics
No open positions right now. Explore more companies on TheJobsMap.